NYSE · Health Information Services · USD
Doximity, Inc. (DOCS) Stock Analysis
Doximity, Inc. (DOCS) is a Health Information Services stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
DOCS Key Statistics
As of Sep 4, 2026Trading
- Open
- $26.77
- Previous Close
- $27.10
- Day's Range
- 26.31–27.03
- 52-Week Range
- 17.15–76.51
- Volume
- 1.98M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.25
Valuation
- Market Cap
- $4.70B
- P/E Ratio
- 32.13
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 17.01
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.59
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 7.16
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.82
Financials (FY)
- Revenue (FY)
- $644.86M+13.05%
- Net Income (FY)
- $196.05M−12.16%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 25.48%
- Shares Outstanding
- 127.35M
- 1-Year Return
- −61.54%
Dividend and dates
- Earnings Date
- November 5, 2026estimated
- Avg Volume
- 4.69M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
DOCS Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −40.49% |
| 2025 | −17.06% |
| 2024 | +90.41% |
| 2023 | −16.45% |
| 2022 | −33.05% |
| 2021 (partial year) | −5.42% |
As of September 4, 2026.
DOCS Revenue and Earnings by Fiscal Year
FY ends March| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $644.86M | $196.05M | 30.4% |
| 2024 | $570.40M | $223.19M | 39.1% |
| 2023 | $475.42M | $147.58M | 31.0% |
| 2022 | $419.05M | $112.82M | 26.9% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $644.86M | $574.54M | $214.92M | $196.05M | 30.4% |
| 2024 | $570.40M | $514.53M | $230.10M | $223.19M | 39.1% |
| 2023 | $475.42M | $424.75M | $171.81M | $147.58M | 31.0% |
| 2022 | $419.05M | $365.56M | $125.11M | $112.82M | 26.9% |
Annual figures as reported, in the company's reporting currency. As of March 31, 2026.
DOCS Valuation vs Health Information Services Median
Median of 53 stocks| Metric | DOCS | Health Information Services median | vs median |
|---|---|---|---|
| P/E | 32.13 | 41.13 | 22% below |
| P/S ratio | 7.16 | 2.66 | 169% above |
| Profit margin | 25.48% | 0.00% | 25.5 pts above |
Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Doximity (NYSE:DOCS): A Quality Investment with Superior Returns on Capital
ChartMill3 Reasons to Avoid DOCS and 1 Stock to Buy Instead
YahooAmplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Know
YahooDoximity (DOCS) Price Target Increased by 12.72% to 30.32
FintelBarclays Maintains Equal-Weight on Doximity, Raises Price Target to $27
BenzingaDoximity (DOCS) Stock Looks Cheap On Cash Flow Yet Fair On Earnings
Yahoo
All 20 articles ↓Show fewer ↑
Doximity (DOCS) Could Be 26% Below Fair Value On Strong Earnings Guidance
YahooA Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know
YahooWhat Investors Should Know of This Doximity Officer's Latest Insider Transaction
YahooDoximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors
YahooDoximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.
YahooDoximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?
YahooRapid7, 8x8, Doximity, Marqeta, and Tenable Shares Are Soaring, What You Need To Know
YahooDoximity (DOCS) Q1 2027 Earnings Call Transcript
YahooDoximity Doubled, Then Gave Most of It Back. Here’s Why the Market Doesn’t Trust the Rally
YahooTruist Lifts Doximity Target to $24 and Stays on Hold
YahooTruist Securities Maintains Hold on Doximity, Raises Price Target to $24
BenzingaAtlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup
YahooWells Fargo Downgrades Doximity (DOCS)
FintelDOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Health Information Services Stocks
Veeva Systems Inc.
$44.54B
BTSGBrightSpring Health Services, Inc.
$12.02B
TEMTempus AI, Inc.
$11.66B
HQYHealthEquity, Inc.
$7.95B
HNGEHinge Health, Inc.
$7.45B
WAYWaystar Holding Corp.
$4.81B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B















